SCHEMBL6308006

SCHEMBL6308006

Cc1nc2ccc(C(=O)O)cc2n1Cc1ccc(-c2cccs2)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 2/20 0.47
▸ TP53 P04637 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ PTGES O14684 2/20 0.41
▸ ACSS2 Q9NR19 1/20 0.40
▸ HDAC3 O15379 1/20 0.40
▸ HDAC4 P56524 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC7 Q8WUI4 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40
▸ HDAC10 Q969S8 1/20 0.40
▸ HDAC11 Q96DB2 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ HDAC9 Q9UKV0 1/20 0.40
▸ HDAC5 Q9UQL6 1/20 0.40
▸ CSF1R P07333 1/20 0.40
▸ KIT P10721 1/20 0.40
▸ SRPK1 Q96SB4 1/20 0.40
▸ RPS6KB2 Q9UBS0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6303364 0.89 PPARG (0.46) PPARGTP53MAPT
SCHEMBL6307363 0.86 PPARG (0.51) PPARGMAPTPTGESACSS2HDAC3
SCHEMBL7651458 0.85 PPARG (0.56) PPARGMAPTACSS2HDAC3HDAC4
SCHEMBL7648938 0.83 PPARG (0.53) PPARGTP53MAPTHDAC3HDAC4
SCHEMBL6298983 0.83 MAPT (0.39) PPARGTP53MAPTCSF1RKIT
SCHEMBL6301259 0.83 PPARG (0.71) PPARGTP53MAPTHDAC3HDAC4
SCHEMBL27548491 0.83 PPARG (0.48) PPARGTP53MAPTACSS2HDAC3
SCHEMBL6134256 0.82 PPARG (0.75) PPARGTP53MAPTHDAC3HDAC4
SCHEMBL6170044 0.82 PPARG (0.64) PPARGACSS2HDAC3HDAC4HDAC1
SCHEMBL6308746 0.82 PPARG (0.56) PPARGTP53MAPTHDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6869950-B1 Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-03-22 — — US disclosed
US-6420409-B1 GLUCOSE TOLERANCE, DIABETES,INSULIN RESISTANCE, POLYCYSTIC OVARY SYNDROME, HYPERLIPIDEMIA, ATHEROSCLEROSIS, CARDIOVASCULAR DISORDERS, HYPERGLYCEMIA, HYPERTENSION, STENOCARDIA, PULMONARY HYPERTENSION, CONGESTIVE HEART FAILURE, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-07-16 — — US disclosed
EP-1142880-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-10 — — EP disclosed
EP-1020452-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 — — EP disclosed
Send feedback